Rytelo (Imetelstat)

• Treatment with Rytelo 47 mg/188 mg injections may cause severe thrombocytopenia, leading to bleeding complications. Regular monitoring of platelet counts is essential to minimize the risk. Ensure medical supervision and dose adjustments as necessary. 
  
• This therapeutic drug can cause neutropenia, significantly lowering white blood cell counts and increasing infection risks. Frequent blood tests are recommended. Consult healthcare professionals before treatment. 
  
• Infusion-related reactions, including fever, chills, and low blood pressure, may occur during Rytelo administration. Close monitoring during infusion is required to manage symptoms effectively. 
  
• Imetelstat may cause embryo-fetal harm, so its use during pregnancy is not recommended. Effective contraception is advised for women of childbearing potential. Ensure proper medical consultation before purchasing Imetelstat for injection for specific patient needs.
  
• Due to the potential risk of serious adverse effects in breastfed infants, women receiving this therapeutic drug should avoid breastfeeding. Seek professional medical advice before initiating therapy.
  

What documents are required to import RYTELO to India?

RYTELO (imetelstat) for injection can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
  
• Import permit if applicable

RYTELO (imetelstat for injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Rytelo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of RYTELO (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Rytelo 47 mg/188 mg injections price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the RYTELO (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Rytelo®?

Imetelstat is a Generic Name for the trade name drug Rytelo®.

What is the Manufacturer’s Name of Rytelo®?

Rytelo® is manufactured by Geron Corporation.

Is Rytelo® approved by the FDA?

Yes, Rytelo® is approved by the FDA. Date of first approval: June 6, 2024.

What is the dosage and form of Rytelo® supplied?

Rytelo® is supplied for injection: 47 mg and 188 mg powder in a single-dose vial for reconstitution for intravenous use.

What are the most common side effects of Rytelo®? 

The most common side effects of Rytelo® are headache, decreased platelets, decreased white blood cells, increased AST, decreased neutrophils, increased alkaline phosphatase, increased ALT, prolonged partial thromboplastin time, fatigue, arthralgia/myalgia, and COVID-19 infections.

How much does Rytelo® 47 mg/188 mg powder for injections cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on Rytelo 47 mg/188 mg cost in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Rytelo® be available in SAARC countries? 

Apart from Gulf countries, Rytelo® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Rytelo® injections in these countries, ensuring access to this therapeutic drug through legal and reliable channels.

Is it safe to buy Rytelo® 47 mg/188 mg powder for injections online in India?

Yes, one can buy Rytelo 47 mg/188 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Rytelo® for injections through legal channels. 

What are the storage conditions of Rytelo® 47 mg/188 mg powder for injections?

Store vials in the original carton at a refrigerated temperature of 2°C to 8°C (36°F to 46°F); avoid freezing.